The Role of Minimal Access Surgery for Metastasectomy and Cytoreduction
This article summarizes findings about the applicability of minimal-access techniques for thoracic and upper gastrointestinal cancers, including those affecting the lung, liver, stomach, and adrenal gland. If metastasectomy and cytoreductive surgery are rapidly evolving, minimal-access surgery in this setting is in its introductory stages. Nevertheless, minimal-access metastasectomy and cytoreductive surgery harbor great potential for selected patients, but further clinical studies are needed.
aJohn Muir Health, 401 Gregory Lane, # 204, Walnut Creek, CA 94523, USA
bHepatobiliary and Pancreas Cancer Program, John Muir Cancer Institute, 1601 Ygnacio Valley Road, Walnut Creek, CA 94598, USA
cThoracic Oncology Program, John Muir Cancer Institute, 1601 Ygnacio Valley Road, Walnut Creek, CA 94598, USA
dMemorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Ave. # 1217, New York, NY 10021, USA